Please use this identifier to cite or link to this item: http://cmuir.cmu.ac.th/jspui/handle/6653943832/55989
Full metadata record
DC FieldValueLanguage
dc.contributor.authorThanita Hiranyatheben_US
dc.contributor.authorDaochompu Nakawiroen_US
dc.contributor.authorTinakon Wongpakaranen_US
dc.contributor.authorNahathai Wongpakaranen_US
dc.contributor.authorPutipong Bookkamanaen_US
dc.contributor.authorManee Pinyopornpanishen_US
dc.contributor.authorNattha Saisavoeyen_US
dc.contributor.authorKamonporn Wannariten_US
dc.contributor.authorSirina Satthapisiten_US
dc.contributor.authorSitthinant Tanchakvaranonten_US
dc.date.accessioned2018-09-05T03:07:25Z-
dc.date.available2018-09-05T03:07:25Z-
dc.date.issued2016-12-12en_US
dc.identifier.issn11782021en_US
dc.identifier.issn11766328en_US
dc.identifier.other2-s2.0-85006789742en_US
dc.identifier.other10.2147/NDT.S124277en_US
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85006789742&origin=inwarden_US
dc.identifier.urihttp://cmuir.cmu.ac.th/jspui/handle/6653943832/55989-
dc.description.abstract© 2016 Hiranyatheb et al. Purpose: Residual symptoms of depressive disorder are major predictors of relapse of depression and lower quality of life. This study aims to investigate the prevalence of residual symptoms, relapse rates, and quality of life among patients with depressive disorder. Patients and methods: Data were collected during the Thai Study of Affective Disorder (THAISAD) project. The Hamilton Rating Scale for Depression (HAMD) was used to measure the severity and residual symptoms of depression, and EQ-5D instrument was used to measure the quality of life. Demographic and clinical data at the baseline were described by mean ± standard deviation (SD). Prevalence of residual symptoms of depression was determined and presented as percentage. Regression analysis was utilized to predict relapse and patients’ quality of life at 6 months postbaseline. Results: A total of 224 depressive disorder patients were recruited. Most of the patients (93.3%) had at least one residual symptom, and the most common was anxiety symptoms (76.3%; 95% confidence interval [CI], 0.71–0.82). After 3 months postbaseline, 114 patients (50.9%) were in remission and within 6 months, 44 of them (38.6%) relapsed. Regression analysis showed that residual insomnia symptoms were significantly associated with these relapse cases (odds ratio [OR]=5.290, 95% CI, 1.42–19.76). Regarding quality of life, residual core mood and insomnia significantly predicted the EQ-5D scores at 6 months postbaseline (B =-2.670, 95% CI, -0.181 to -0.027 and B =-3.109, 95% CI, -0.172 to -0.038, respectively). Conclusion: Residual symptoms are common in patients receiving treatment for depressive disorder and were found to be associated with relapses and quality of life. Clinicians need to be aware of these residual symptoms when carrying out follow-up treatment in patients with depressive disorder, so that prompt action can be taken to mitigate the risk of relapse.en_US
dc.subjectMedicineen_US
dc.subjectNeuroscienceen_US
dc.titleThe impact of residual symptoms on relapse and quality of life among Thai depressive patientsen_US
dc.typeJournalen_US
article.title.sourcetitleNeuropsychiatric Disease and Treatmenten_US
article.volume12en_US
article.stream.affiliationsMahidol Universityen_US
article.stream.affiliationsChiang Mai Universityen_US
article.stream.affiliationsDepartment of Psychiatry Khon Kaen Hospitalen_US
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.


Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.